Committees : Surrey Priorities Committee
You are here : Home > Committees : Surrey Priorities Committee
Committee Types
Please select an organisation name from the list below to view associated profiles and decisions.
Committee
- ASPH DTC
- East Surrey CCG Medicines Programme Board
- East Surrey MOG
- Epsom St Helier NDAIG
- ESCCG sub-committee of North Place Alliance Clinical Strategy Committee (formerly Clinical Executive
- Guildford and Waverley MOG
- Medicines Optimisation Operational Group (MOOG)
- Not Set
- NW Surrey Medicines Optimisation Group
- Primary Care Medicines Optimisation Clinical reference Group (PCMOCRG)
- RSFT DTC
- SASH DTG
- Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
- Surrey Downs CCG Prescribing Leads Meeting
- Surrey Downs MOG
- Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
- Surrey Heartlands Medicines Optimisation Board (MOB)
- Surrey Heartlands Medicines Safety Committee (MSC)
- Surrey Medicines Commissioners Group
- Surrey Priorities Committee
Trust
Profiles (0)
No records returned.
Committee Recommendations (1)
04 Mar 15
The Surrey Priorities Committee has considered the PCN evidence review and the NICE ESNM40 (Evidence Summary: New Medicine), regarding dapoxetine for the treatment of premature ejaculation:
The commissioning of dapoxetine for premature ejaculation is considered LOW PRIORITY and it is not recommended for routine prescribing.
Dapoxetine should therefore have a BLACK status on the Surrey traffic light system.
The commissioning of dapoxetine for premature ejaculation is considered LOW PRIORITY and it is not recommended for routine prescribing.
Dapoxetine should therefore have a BLACK status on the Surrey traffic light system.